and pulmonary hypertension may be particularly relevant to the pathophysiology heart failure in patients with preserved ejection fraction, there is compelling rationale for extending the ...
The two primary end points were a composite of adjudicated death from cardiovascular causes or a worsening heart-failure event (assessed in a time-to-first-event analysis) and the change from ...
Role of the RAAS in the Pathophysiology of Heart Failure ACE inhibitors have no effect on angiotensin II formed by alternate pathways. In contrast, ARBs would be expected to inhibit the biologic ...
Dilated cardiomyopathy (DCM) is one of the most common causes of heart failure, and thereby an S3. DCM occurs when the walls of one or both ventricles (the heart's lower chambers) distend and enlarge, ...
8,9Such readmission rates are usually higher than the other major causes of hospitalisation, including stroke, hip fracture, and respiratory disease. Moreover, although there is evidence to suggest ...
A new study by researchers at Intermountain Health in Salt Lake City finds that 40 percent of newly diagnosed heart failure patients ... is a heart condition that causes the upper chambers of ...
"Obesity contributes to worsening heart failure, and while tirzepatide causes considerable weight loss, research is lacking on its effects on cardiovascular outcomes," said lead study author ...
A robust and systematic approach is key to ensuring that people living with heart failure with preserved ejection fraction (HFpEF) receive a timely and accurate diagnosis and guideline-based therapies ...
The two primary outcomes were a composite of death from cardiovascular causes or new or worsening heart failure, evaluated as the total number of events; and a composite of the first occurrence of ...
Heart failure often develops slowly over time. It is a condition in which the heart does not pump as strongly as it should. There are important things that you can do to help take care of yourself and ...
For all indications, more than 191.5 million prescriptions for beta blockers were filled in 2010, making them part of standard therapy and the 4th most commonly prescribed drug for all indications.
AIM To investigate the effect of several types of congenital heart disease (CHD) on nutrition and growth. PATIENTS AND METHODS The prevalence of malnutrition and growth failure was investigated in 89 ...